Colorectal, Gastroesophageal and Pancreatic Cancer | Beyond the Guidelines: Clinical Investigator Perspectives on the Management of Colorectal, Gastroesophageal and Pancreatic Cancer

published 2 weeks ago by Dr Neil Love

Proceedings from a CME symposium held at the 2020 Gastrointestinal Cancers Symposium. Featuring perspectives from Drs Crystal Denlinger, Howard S Hochster, John L Marshall, Michael J Overman, Philip A Philip and Prof Eric Van Cutsem. Introduction — Dr Neil Love (00:00) The Emergence of Targeted Therapy for Patients with Metastatic Colorectal Cancer (mCRC) and BRAF V600E Tumor Mutations; HER2 and Other Potential Biomarkers — Dr Hochster (16:20) Lingering Questions in the Selection and Sequence of Therapy for Patients with mCRC — Dr Marshall (44:23) Current and Emerging Role of Immune Checkpoint Inhibitors in the Management of mCRC — Dr Overman (1:05:39) Optimal Management of Metastatic Gastric/Gastroesophageal Cancer — Dr Denlinger (1:33:29) Contemporary Treatment Approaches for Patients with Pancreatic Cancer — Dr Philip (1:53:28) PARP Inhibition in Pancreatic Cancer; Promising Investigational Strategies — Prof Van Cutsem (2:15:15) CME information and select publications

more episodes from Research To Practice | Oncology Videos